Design and synthesis of pyrrolo[3,2-d]pyrimidine HER2/EGFR dual inhibitors: Improvement of the physicochemical and pharmacokinetic profiles for potent in vivo anti-tumor efficacy-Reference-Cited by-同舟云学术

Design and synthesis of pyrrolo[3,2-d]pyrimidine HER2/EGFR dual inhibitors: Improvement of the physicochemical and pharmacokinetic profiles for potent in vivo anti-tumor efficacy

Published:2012-10 Issue:20 Volume:20 Page:6171-6180
ISSN:0968-0896
Container-title:Bioorganic & Medicinal Chemistry
language:en
Short-container-title:Bioorganic & Medicinal Chemistry

Author:

Kawakita Youichi,Miwa Kazuhiro,Seto Masaki,Banno Hiroshi,Ohta Yoshikazu,Tamura Toshiya,Yusa Tadashi,Miki Hiroshi,Kamiguchi Hidenori,Ikeda Yukihiro,Tanaka Toshimasa,Kamiyama Keiji,Ishikawa Tomoyasu

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference38 articles.

1. Transplacental Carcinogenesis by Stilbestrol

2. The erbB gene of avian erythroblastosis virus is a member of the src gene family

3. Tyrosine kinases as targets in cancer therapy – successes and failures

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in Small-Molecule Dual Inhibitors Targeting EGFR and HER2 Receptors as Anti-Cancer Agents;Current Medicinal Chemistry;2024-06-10

2. Computational insights into overcoming resistance mechanisms in targeted therapies for advanced breast cancer: focus on EGFR and HER2 co-inhibition;Journal of Biomolecular Structure and Dynamics;2024-01-17

3. Privileged Scaffolds in Drug Discovery against Human Epidermal Growth Factor Receptor 2 for Cancer Treatment;Current Pharmaceutical Design;2023-12

4. Ligand and structure based hierarchical virtual screening cascade for finding novel epidermal growth factor receptor inhibitors;Chemical Biology & Drug Design;2023-10-17

5. Recent Advances in Structural Modification Strategies for Lead Optimization of Tyrosine Kinase Inhibitors to Explore Novel Anticancer Agents;Current Medicinal Chemistry;2023-07